Source: Frontiers in oncology. Unidade: FM
Subjects: LEUCEMIA, IMUNOTERAPIA, TRANSPLANTE DE MEDULA ÓSSEA
ABNT
COUTO, Samuel Campanelli Freitas et al. Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?. Frontiers in oncology, v. 13, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/56001. Acesso em: 28 set. 2024.APA
Couto, S. C. F., Kowes, A., Aurabi, C. S., Oliveira, T. G. M., Klinger, P. H. dos S., & Rocha, V. G. (2023). Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL? Frontiers in oncology, 13. doi:10.3389/fonc.2023.1195759NLM
Couto SCF, Kowes A, Aurabi CS, Oliveira TGM, Klinger PH dos S, Rocha VG. Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL? [Internet]. Frontiers in oncology. 2023 ; 13[citado 2024 set. 28 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56001Vancouver
Couto SCF, Kowes A, Aurabi CS, Oliveira TGM, Klinger PH dos S, Rocha VG. Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL? [Internet]. Frontiers in oncology. 2023 ; 13[citado 2024 set. 28 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56001